In the study, Pan02: A murine model of pancreatic cancer, Labcorp researcher Sumithra Urs, PhD investigated tumor responses to radiotherapy, immunomodulation, and combination therapy. See more below and the original research here.
Sheri Barnes of Labcorp presented as part of an AACR webinar series on her research, Focal Radiation Enhances Anti-Tumor Activity and immunomodulation of checkpoint blockade in the GL261-luc Orthotopic Murine Glioma Model. https://youtu.be/AxFF_vBdk4U
Xstrahl recently installed its 100th 3D cabinet irradiator at Duke University, the latest institution to use SARRP for translational radiation research. To mark this important milestone, we wanted to spotlight Duke’s research interests along with highlights from a few...
In this publication, Analysis of clonogenic growth in vitro, researchers expanded on the clonogenic assay protocol developed by Puck & Marcus. Researchers expanded the protocol to examine clonogenic survival of cancer and nonmalignant cells in response to radio-...
In the study, Hepa 1-6: A murine model of hepatocellular carcinoma, Labcorp researcher, Sumithra Urs, studied an HCC tumor model's response to radiation with SARRP. See more below and the full article here.
The below graphic displays highlights from the study, "Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models" by HJ Yun, HJ Kim, J Kim, SY Kim, HS Chang, CS...
This data comes from the presentation, "Radiation Enhances Anti-Tumor Activity of Checkpoint Blockade in Syngeneic Tumor Models" by Covance researchers Sumithra Urs, Mary Anne Meade, Kevin Guley, Sarah Krueger, Alden Wong, Scott Wise, and Maryland Rosenfeld Franklin....
Precise, consistent dosimetry is crucial for accurate, repeatable research. Here at Xstrahl, we strive to offer researchers all of the tools and support you need to ensure accurate radiation dosage. Learn how we are doing that with our research systems and support...
In the recent study, Radiotherapy Delivered Before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer, researchers compared various forms of treatment including radiotherapy, oral palbociclib, or a combination of both. Researchers found that...
Contact Us